Proton pump inhibitors are associated with increased risk of development of chronic kidney disease

被引：0
作者：
Pradeep Arora
Anu Gupta
Mojgan Golzy
Nilang Patel
Randolph L. Carter
Kabir Jalal
James W. Lohr
机构：
[1] University at Buffalo,Department of Medicine
[2] Division of Nephrology at VA Medical Center,Department of Biostatistics
[3] University at Buffalo,Department of Medicine
[4] Virginia Commonwealth University,undefined
来源：
BMC Nephrology | / 17卷
关键词：
Chronic kidney disease; Death; Outcomes; Proton pump inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Proton pump inhibitors use and risk of chronic kidney disease: Evidence-based meta-analysis of observational studies
    Hussain, Salman
    Sing, Ambrish
    Habib, Anwar
    Najmi, Abul Kalam
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2019, 7 (01): : 46 - 52
  • [32] Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank
    Zhang, Xing-Yu
    He, Qiang-Sheng
    Jing, Zhong
    He, Juan-Xia
    Yuan, Jin-Qiu
    Dai, Xiao-Yu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence
    Rattazzi, Marcello
    Villalta, Sabina
    De Lucchi, Lara
    Sponchiado, Alessandra
    Galliazzo, Silvia
    Faggin, Elisabetta
    Pagliara, Valeria
    Zilli, Chiara
    Callegari, Elena
    Caberlotto, Livio
    Puato, Massimo
    Pauletto, Paolo
    THROMBOSIS RESEARCH, 2017, 160 : 32 - 37
  • [34] Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review
    Ejaz Cheema
    Journal of Pharmaceutical Policy and Practice, 12
  • [35] Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review
    Cheema, Ejaz
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2019, 12 (01)
  • [36] The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease
    Kamal, Faisal
    Khan, Muhammad A.
    Molnar, Miklos Z.
    Howden, Colin W.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (06) : 468 - 476
  • [37] Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis
    Hyun Jin Song
    Hyun-Ju Seo
    Xinyi Jiang
    Nakyung Jeon
    Yoon Jae Lee
    In-Hyuk Ha
    European Journal of Clinical Pharmacology, 2024, 80 : 367 - 382
  • [38] Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study
    Li, Cheng-Yuan
    Dai, Ying-Xiu
    Chang, Yun-Ting
    Bai, Ya-Mei
    Tsai, Shih-Jen
    Chen, Tzeng-Ji
    Chen, Mu-Hong
    DERMATOLOGY, 2021, 237 (06) : 884 - 890
  • [39] Low Serum Zinc Concentration Is Associated With Infection Particularly in Patients With Stage 5 Chronic Kidney Disease Medicated with Proton Pump Inhibitors
    Saka, Yosuke
    Naruse, Tomohiko
    Matsumoto, Jun
    Takeda, Yuka
    Onogi, Chikao
    Yokoi, Junpei
    Kato, Akihisa
    Tawada, Naoto
    Noda, Yuhei
    Niwa, Syunsuke
    Mimura, Tetsushi
    Watanabe, Yuzo
    JOURNAL OF RENAL NUTRITION, 2021, 31 (06) : 579 - 585
  • [40] Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis
    Wijarnpreecha, Karn
    Thongprayoon, Charat
    Chesdachai, Supavit
    Panjawatanana, Panadeekarn
    Ungprasert, Patompong
    Cheungpasitporn, Wisit
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (10) : 2821 - 2827
12345